D

Day One Biopharmaceuticals Inc
NASDAQ:DAWN

Watchlist Manager
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Watchlist
Price: 8.36 USD -0.71% Market Closed
Market Cap: 858.4m USD

Wall Street
Price Targets

DAWN Price Targets Summary
Day One Biopharmaceuticals Inc

Wall Street analysts forecast DAWN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DAWN is 22.7 USD with a low forecast of 16.16 USD and a high forecast of 30.45 USD.

Lowest
Price Target
16.16 USD
93% Upside
Average
Price Target
22.7 USD
171% Upside
Highest
Price Target
30.45 USD
264% Upside
Day One Biopharmaceuticals Inc Competitors:
Price Targets
CRBU
Caribou Biosciences Inc
534% Upside
EVAX
Evaxion Biotech A/S
103% Upside
VRTX
Vertex Pharmaceuticals Inc
10% Upside
002252
Shanghai RAAS Blood Products Co Ltd
11% Upside
XNCR
Xencor Inc
73% Upside
CNTB
Connect Biopharma Holdings Ltd
222% Upside
688180
Shanghai Junshi Biosciences Co Ltd
28% Downside
VCYT
Veracyte Inc
15% Upside

Revenue
Forecast

Revenue Estimate
Day One Biopharmaceuticals Inc

The compound annual growth rate of Day One Biopharmaceuticals Inc's revenue for the next 4 years is 36%.

N/A
Past Growth
36%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Day One Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Day One Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DAWN's stock price target?
Price Target
22.7 USD

According to Wall Street analysts, the average 1-year price target for DAWN is 22.7 USD with a low forecast of 16.16 USD and a high forecast of 30.45 USD.

What is Day One Biopharmaceuticals Inc's Revenue forecast?
Projected CAGR
36%

The compound annual growth rate of Day One Biopharmaceuticals Inc's revenue for the next 4 years is 36%.

Back to Top